2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). (September 2015)

Record Type:: Journal Article
Title:: 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC). (September 2015)
Main Title:: 2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC)
Authors:: Embleton, A.C.
Perren, T.J.
Cook, A.
Kent, E.
Pfisterer, J.
Ledermann, J.A.
Pujade-Lauraine, E.
Kristensen, G.
Beale, P.
Cervantes, A.
Farrelly, L.
Kaplan, R.
Parmar, M. K.B.
Oza, A.M.
Abstract:
Is Part Of:: European journal of cancer. Volume 51:(2015)Supplement 3
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Issue Display:: Volume 51, Issue 3 (2015)
Year:: 2015
Volume:: 51
Issue:: 3
Issue Sort Value:: 2015-0051-0003-0000
Page Start:: S546
Page End:
Publication Date:: 2015-09
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)31514-3 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2030.xml